| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.0073 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.006 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |